scholarly journals IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients

Oncotarget ◽  
2017 ◽  
Vol 8 (10) ◽  
pp. 16887-16898 ◽  
Author(s):  
Mariantonietta Di Salvatore ◽  
Filippo Pietrantonio ◽  
Armando Orlandi ◽  
Marzia Del Re ◽  
Rosa Berenato ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Treatment Outcomes ◽  
Cancer Patients ◽  
Line Treatment ◽  
First Line ◽  
Colorectal Cancer Patients ◽  
Enos Polymorphisms ◽  
First Line Treatment

scholarly journals RAS mutations testing and choice of first-line treatment for metastatic colorectal cancer patients in our institute

2017 ◽  
Vol 28 ◽  
pp. ix98
Author(s):  
Takashi Iwata ◽  
Eiki Ojima ◽  
Tomomi Mohri ◽  
Tomohumi Noguchi ◽  
Kiyoshi Hashimoto ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Line Treatment ◽  
First Line ◽  
Ras Mutations ◽  
Colorectal Cancer Patients ◽  
First Line Treatment

An Oxaliplatin + 5-Fluorouracil Bolus + Folinic Acid (BFOL) Regimen as First-Line Treatment in Metastatic Colorectal Cancer Patients

2007 ◽  
Vol 93 (6) ◽  
pp. 557-561
Author(s):  
Nicla La Verde ◽  
Marina Garassino ◽  
Claudia Bareggi ◽  
Paola Sburlati ◽  
Karen Borgonovo ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Folinic Acid ◽  
Cancer Patients ◽  
Line Treatment ◽  
First Line ◽  
Colorectal Cancer Patients ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document